» Articles » PMID: 37849668

Vascular Grafts: Technology Success/Technology Failure

Overview
Journal BME Front
Date 2023 Oct 18
PMID 37849668
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular prostheses (grafts) are widely used for hemodialysis blood access, trauma repair, aneurism repair, and cardiovascular reconstruction. However, smaller-diameter (≤4 mm) grafts that would be valuable for many reconstructions have not been achieved to date, although hundreds of papers on small-diameter vascular grafts have been published. This perspective article presents a hypothesis that may open new research avenues for the development of small-diameter vascular grafts. A historical review of the vascular graft literature and specific types of vascular grafts is presented focusing on observations important to the hypothesis to be presented. Considerations in critically reviewing the vascular graft literature are discussed. The hypothesis that perhaps the "biocompatible biomaterials" comprising our vascular grafts-biomaterials that generate dense, nonvascularized collagenous capsules upon implantation-may not be all that biocompatible is presented. Examples of materials that heal with tissue reconstruction and vascularity, in contrast to the fibrotic encapsulation, are offered. Such prohealing materials may lead the way to a new generation of vascular grafts suitable for small-diameter reconstructions.

Citing Articles

Monascus pigment-protected bone marrow-derived stem cells for heart failure treatment.

Yue T, Zhang W, Pei H, Danzeng D, He J, Yang J Bioact Mater. 2024; 42:270-283.

PMID: 39285916 PMC: 11403898. DOI: 10.1016/j.bioactmat.2024.08.038.


Manufacturing and validation of small-diameter vascular grafts: A mini review.

Hernandez-Sanchez D, Comtois-Bona M, Munoz M, Ruel M, Suuronen E, Alarcon E iScience. 2024; 27(6):109845.

PMID: 38799581 PMC: 11126982. DOI: 10.1016/j.isci.2024.109845.


Enhanced hemocompatibility and rapid magnetic anastomosis of electrospun small-diameter artificial vascular grafts.

Liu P, Liu X, Yang L, Qian Y, Lu Q, Shi A Front Bioeng Biotechnol. 2024; 12:1331078.

PMID: 38328445 PMC: 10847591. DOI: 10.3389/fbioe.2024.1331078.


Mitochondria as a therapeutic: a potential new frontier in driving the shift from tissue repair to regeneration.

Main E, Cruz T, Bowlin G Regen Biomater. 2023; 10:rbad070.

PMID: 37663015 PMC: 10468651. DOI: 10.1093/rb/rbad070.

References
1.
Edwards W . Arterial grafts: past, present, and future. Arch Surg. 1978; 113(11):1225-33. DOI: 10.1001/archsurg.1978.01370230015001. View

2.
Fathi-Karkan S, Banimohamad-Shotorbani B, Saghati S, Rahbarghazi R, Davaran S . A critical review of fibrous polyurethane-based vascular tissue engineering scaffolds. J Biol Eng. 2022; 16(1):6. PMC: 8951709. DOI: 10.1186/s13036-022-00286-9. View

3.
Rodriguez A, Meyerson H, Anderson J . Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A. 2008; 89(1):152-9. PMC: 3864694. DOI: 10.1002/jbm.a.31939. View

4.
Pashneh-Tala S, MacNeil S, Claeyssens F . The Tissue-Engineered Vascular Graft-Past, Present, and Future. Tissue Eng Part B Rev. 2015; 22(1):68-100. PMC: 4753638. DOI: 10.1089/ten.teb.2015.0100. View

5.
Wystrychowski W, McAllister T, Zagalski K, Dusserre N, Cierpka L, LHeureux N . First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access. J Vasc Surg. 2013; 60(5):1353-1357. DOI: 10.1016/j.jvs.2013.08.018. View